Siga Technologies (SIGA) Return on Capital Employed (2011 - 2025)
Siga Technologies (SIGA) posted Return on Capital Employed of 43.28% for Q3 2025, down 6.43% on a QoQ basis from 46.25% in Q2 2025, and down 1763.0% year-over-year from 2.6% in Q3 2024.
Siga Technologies (SIGA) Return on Capital Employed (2011 - 2025) Analysis & Trends
Siga Technologies' Return on Capital Employed history runs 15 years deep, the most recent figure standing at 43.28% for Q3 2025.
- Quarterly Return on Capital Employed fell 1763.0% year-over-year to 43.28% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 43.28% (down 1763.0% YoY) and the FY2024 annual result came in at 31.24%, down 1778.0% from the prior year.
- Return on Capital Employed was 43.28% for Q3 2025 at Siga Technologies, down from 46.25% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 89.59% in Q3 2022 and bottomed at 8.1% in Q3 2023.
- A 5-year average of 43.35% and a median of 46.25% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed surged 7068 bps — and 2023, when it sank 9769 bps.
- Siga Technologies' Return on Capital Employed stood at 61.59% in 2021, then slumped by 61 bps to 23.97% in 2022, then soared by 129 bps to 54.92% in 2023, then slumped by 34 bps to 35.98% in 2024, then advanced by 20 bps to 43.28% in 2025.
- Business Quant data shows SIGA's Return on Capital Employed at 43.28% in Q3 2025, 46.25% in Q2 2025, and 25.91% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 43.28% |
| Jun 30, 2025 | 46.25% |
| Mar 31, 2025 | 25.91% |
| Dec 31, 2024 | 35.98% |
| Sep 30, 2024 | 60.90% |
| Jun 30, 2024 | 52.27% |
| Mar 31, 2024 | 55.77% |
| Dec 31, 2023 | 54.92% |
| Sep 30, 2023 | -8.10% |
| Jun 30, 2023 | 23.47% |
| Mar 31, 2023 | 24.58% |
| Dec 31, 2022 | 23.97% |
| Sep 30, 2022 | 89.59% |
| Jun 30, 2022 | 59.60% |
| Mar 31, 2022 | 46.59% |
| Dec 31, 2021 | 61.59% |
| Sep 30, 2021 | 18.91% |
| Jun 30, 2021 | 45.00% |
| Mar 31, 2021 | 63.24% |
| Dec 31, 2020 | 62.53% |